Studies by the Heiko Hermeking group and Junjeong Choi group further confirmed that IL-6/STAT3 signalling facilitates the epithelial-mesenchymal transition (EMT) and metastasis of colorectal cancer cells (CRC) [8] and breast cancer cells [9], respectively. This evidence concerns the gene STAT3 and breast carcinoma.